Tag: JPIAMR

October 2017: Management Board meeting in Stockholm

Anders BjersNews and press

We gathered members of JPIAMR for Management Board meeting in Stockholm on October 10-11. Two dynamic days with member nations represented. Sharing AMR insights and updates on the actions of JPIAMR. Coordination, collaboration, calls and developments in focus.

Many items and areas covered, including welcoming new member South Africa who was represented by Dr. Richard Gordon. The mapping project is underway, continued expansion of JPIAMR, updates from EC and the development of JPIAMR Virtual Research Institute.

Thank you all for making it to Stockholm.

Workshop: Environmental Dimensions of AMR

Anders BjersNews and press

Full focus on the impact of environment on AMR when a global group of scientist collaborated during two intense days. Themes discussed: Evolution, Transmission and Interventions. The purpose of the workshop was to explore and identify critical research needs that relate to the environmental dimensions of AMR, both in the longer term for providing input to an updated JPIAMR Strategic Research Agenda, but also in the shorter term to provide guidance for specific calls. Creating more insights on  what role environment plays for antibiotic resistance. We can not exclude the importance of environmental dimensions from the complex context of AMR.

Please, find an article about the report of the outcomes from the workshop.

The workshop in Gothenburg was hosted together with CARe – Centre for Antibiotic Resistance Research at University of Gothenburg.

We made a few interviews during the workshop, please view the videos below.

We say thank you to all of you who participated!

New WHO Report: Current Clinical Pipeline Insufficient

Anna SundinNews and press

The WHO review shows that the current clinical pipeline is still insufficient to mitigate the threat of antimicrobial resistance.

JPIAMR contributes to finding solutions to the challenges presented by WHO. JPIAMR is processing current and future calls that funds research on the very challenges highlighted in the report. Among with several ground breaking activities.

WHO points out:

  • More investments needed in basic science, drug discovery and clinical development.
  • Most of the agents in the pipeline are modifications of existing antibiotic classes. They are only short term solutions as they usually cannot overcome multiple existing resistance mechanisms and do not control the growing number of pan-resistant pathogens.
  • More innovative products are required against pathogens with no cross- or co-resistance to existing classes.
  • Although oral formulations for community diseases associated with high morbidity are essential globally, few oral antibiotics for infections caused by Gram-negative pathogens are in the pipeline.

As of May 2017, a total of 51 antibiotics (including combinations) and 11 biologicals were in the clinical pipeline with 42 new therapeutic entities (33 antibiotics and nine biologicals) that target priority pathogens, seven products for tuberculosis (TB) and nine for C.difficile infections (seven antibiotics and two biologicals) . The qualitative analysis shows a lack of potential treatment options for priority resistant bacteria, especially for multidrug- and extensively drug-resistant Gram-negative pathogens.

The full report is now available,  please click here to view it.

India, South Africa and Egypt are New Members of JPIAMR

Anders BjersNews and press

JPIAMR Becomes Global Collaborative Platform on Antimicrobial Resistance

On 29 June 2017, India, South Africa and Egypt was accepted as a new members of the Joint Programming Initiative on Antimicrobial Resistance (JPIAMR). Now 26 countries are members of the global collaborative platform and involved in the mission to curb antimicrobial resistance (AMR).

” Antimicrobial Resistance is a serious threat that must be acted on globally, and we are delighted to expand the collaborative platform to include India, South Africa and Egypt” said Carlos Segovia, Chair of the JPIAMR Management Board. “Having India as a member means that the world’s second largest country acknowledges JPIAMR as a key platform for harnessing antimicrobial resistance. With South Africa and Egypt as active members participating in calls, that shows they too believe in JPIAMR as a unique global platform that truly advances AMR research and results. We welcome their capacities and capabilities to further strengthen and define the common Strategic Research Agenda that members of JPIAMR develop. Now we all work together”, concludes Segovia.

The new EC Action Plan on AMR outlines JPIAMR as a key mechanism for global collaboration, coordinating calls and for aligning a strategic research agenda to tackle AMR. Now JPIAMR is a global platform were countries come together as members because they trust the organisation. Member countries wants to be part of multilateral calls and there is no other platform on AMR, in the world.

For more information, please contact the JPIAMR secretariat at the Swedish Research Council in Stockholm.

Download: Press Release JPIAMR New Members to Global Platform on AMR 170629.

—

Point of contact for media inquiries:

Mr. Anders Bjers, Communications Manager JPIAMR

E-mail: anders.bjers@vr.se

Direct: +46-8-546 44 068

Mobile: +46-73-344 03 77

 

 

20 Transnational Research Projects enters next step of fifth Call

Anna SundinNews and press

Now twenty transnational research projects are invited to submit full applications within the JPIAMRs fifth Joint Call on Prevention and Intervention Strategies to control AMR infections.

Earlier this year the JPIAMR announced its fifth joint call on “Prevention and Intervention Strategies to control AMR infections”. As the deadline for submitting a pre-proposal passed on March 21st, 53 transnational consortia had submitted applications. After evaluation by a panel of international reviewers, twenty of the projects have been invited to submit a full application. The deadline for the full application is on July 4th. For more information, please visit the call page.

Facts about the fifth joint call:

The JPIAMR, in partnership with fifteen countries: Belgium, Canada, Czech Republic, Germany, Ireland, Israel, Italy, Latvia, Netherlands, Norway, Poland, Romania, Spain, Sweden and Switzerland, launched a fifth joint call for transnational research Projects.

The call targets research in the following topic:

Comparison of prevention, control and intervention strategies for AMR infections through multidisciplinary studies, including One Health approaches.